Takeda Pharmaceutical Faces Oversold Conditions (TAK)

Avatar photo

Shares of Takeda Pharmaceutical Co Ltd (TAK) traded at $16.07 on Friday, indicating an oversold condition with a Relative Strength Index (RSI) reading of 25.9. An RSI below 30 typically suggests that a stock is oversold. In contrast, the S&P 500 ETF (SPY) currently has an RSI of 72.1.

Over the past year, TAK’s stock has fluctuated between a low of $12.99 and a high of $18.895, with the last recorded trade at $16.25. This performance can signal potential buying opportunities for investors as the heavy recent selling may be exhausting.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now